Practical strategies for overcoming challenges in the development of AAV vectors for gene therapy

Gene therapy promises to treat and potentially cure a disease by correcting its underlying genetic cause. While gene therapies that utilize AAV vectors have shown encouraging results —including a few approved by the FDA and/or the EMA — they are still facing challenges. Particularly for AAV-based gene therapy, researchers are still figuring out the analytical characterization strategy of the viral vectors and quality control parameters. This webinar provides an overview of analytical challenges and how different techniques are used in the characterization of AAV vectors.

Dr. Santosh Khatwani, Associate Director of Analytical Development at Sangamo Therapeutics, tells us about how he approaches analytical characterization of AAV vectors and uses two case studies as examples of the challenges he faces.

Dr. Xiaoying Jin, a Sr. Principal Scientist who has worked at Sanofi for 20 years and the lead of a group that specializes in the characterization of AAV vectors, presents how she uses LC-MS to characterize AAV capsid proteins, which are critical for viral infectivity and vector potency.

Previous Video
DLS easily explained: What it tells you about your protein
DLS easily explained: What it tells you about your protein

Join this webinar to learn about the physical phenomenon that drives Dynamic Light Scattering (DLS), and se...

Up next
Mischievous membrane proteins (and how to tame them)
Mischievous membrane proteins (and how to tame them)

Are you struggling to tame your mischievous membrane proteins? Find out how NanoTemper can help you to char...


Sign up to receive
the latest NanoTemper news, product updates, event announcements and more

First Name
Last Name
Company Name
Agree to Subscribe & Privacy Policy*
*I have fully read, understood and agree to the Privacy Policy. I accept the storing and processing of my personal data by NanoTemper as described in the Privacy Policy.

By completing this form, you provide us consent to contact you with educational content, news and information about our products, services and events. You may unsubscribe at any time.
Thank you!
Error - something went wrong!